PLA2G6 Gene PARK14 Parkinson Genetic Test
Are you concerned about Parkinson’s disease? DNA Labs UAE offers the PLA2G6 Gene PARK14 Parkinson Genetic Test to provide valuable insights into the genetic causes of this neurodegenerative disorder.
Test Components and Price
The PLA2G6 Gene PARK14 Parkinson Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for a comprehensive evaluation of genetic variations.
Test Type and Doctor
The PLA2G6 Gene PARK14 Parkinson Genetic Test falls under the category of Neurological Disorders. It is recommended to consult a Neurologist for this test.
Test Department
The test is conducted by the Genetics department at DNA Labs UAE.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is undergoing the PLA2G6 Gene PARK14 Parkinson NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by PLA2G6 Gene PARK14 Parkinson.
Test Details
The PLA2G6 gene, also known as PARK14, is associated with Parkinson’s disease. Mutations in this gene can lead to early-onset Parkinson’s disease, specifically a rare form called PARK14. This form of the disease typically manifests before the age of 40 and may present with additional symptoms such as dystonia, rapid eye movement sleep behavior disorder, and cognitive impairment.
NGS genetic testing for the PLA2G6 gene enables the identification of mutations or variations that may contribute to Parkinson’s disease. This information is valuable for diagnosing the disease, understanding its progression, and potentially guiding treatment decisions.
It is important to note that not all cases of Parkinson’s disease are caused by genetic mutations, as environmental factors also play a role. Therefore, genetic testing may not be necessary or helpful for everyone with Parkinson’s disease. However, it is recommended for individuals with early-onset Parkinson’s disease or a strong family history of the disease.
If you are considering genetic testing for Parkinson’s disease, it is best to consult with a healthcare professional or a genetic counselor. They can provide guidance on the appropriateness and implications of testing, as well as help determine if NGS genetic testing for the PLA2G6 gene or other Parkinson’s-related genes is suitable for your specific situation.
Test Name | PLA2G6 Gene PARK14 Parkinson Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PLA2G6 Gene PARK14 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLA2G6 Gene PARK14 Parkinson |
Test Details |
The PLA2G6 gene, also known as PARK14, is a gene associated with Parkinson’s disease. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously, allowing for a more comprehensive evaluation of genetic variations. The PLA2G6 gene mutation is one of the known genetic causes of early-onset Parkinson’s disease. Mutations in this gene can lead to a rare form of Parkinson’s disease called PARK14. This form of the disease typically presents with symptoms before the age of 40 and is often associated with additional features such as dystonia (involuntary muscle contractions), rapid eye movement sleep behavior disorder, and cognitive impairment. NGS genetic testing for the PLA2G6 gene can help identify mutations or variations in this gene that may be contributing to Parkinson’s disease. This information can be valuable for diagnosing Parkinson’s disease, understanding disease progression, and potentially guiding treatment decisions. It’s important to note that not all cases of Parkinson’s disease are caused by genetic mutations, and most cases are believed to be a result of a combination of genetic and environmental factors. Therefore, genetic testing may not be necessary or helpful for everyone with Parkinson’s disease. It is typically recommended for individuals with early-onset Parkinson’s disease or a strong family history of the disease. If you are considering genetic testing for Parkinson’s disease, it is best to consult with a healthcare professional or a genetic counselor who can provide guidance on the appropriateness and implications of testing. They can help determine if NGS genetic testing for the PLA2G6 gene or other Parkinson’s-related genes is appropriate for your specific situation. |